Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion type Assertion NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_head.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion evidence source_evidence_literature NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion SIO_000772 15256482 NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion wasDerivedFrom befree-20140225 NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion wasGeneratedBy ECO_0000203 NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.